In this study, drug treatment could significantly enhance SERCA2a expression in the HF mice model, thereby activating the calmodulin DHPR and Cav1.2 while reducing the CaMKII and CREB phosphorylation. The gene discussed is CACNA1C; the disease is hydrops fetalis.